AbbVie sues over selection of Botox for IRA negotiations
Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...
AI Summary: AbbVie has filed suit challenging the federal decision to include Botox in Medicare’s drug price negotiation program, arguing the selection process was flawed and that the move could imperil innovation and pricing strategies. The lawsuit seeks to block or alter implementation while the industry and regulators brace for legal precedent.
Kaiser Permanente, DoL reach settlement over mental health access
fiercehealthcare - Kaiser Foundation Health Plan has agreed to a settlement with the Department of Labor that resolves multiple investigations into access for mental health and substance abuse services.
AI Summary: Kaiser Foundation Health Plan reached a settlement with the U.S. Department of Labor resolving investigations into alleged failures to provide adequate mental‑health access. The move comes amid rolling labor actions at Kaiser — pharmacy and lab employees briefly struck and later stood down while nurse‑led walkouts continued — exposing labor tensions and regulatory pressure.
Thousands of NYC nurses return to work, but one major strike goes on
medicalxpress - A monthlong nurses strike in New York City is coming to an end, but not for everyone.
AI Summary: After weeks of labor turmoil, most striking New York City nurses have tentatively returned under new agreements, but a substantial contingent at a major hospital remains on strike. Patients and families report care disruptions and uncertainty as remaining negotiations continue, highlighting strain on hospitals and lingering tensions between staff and management.
500M records exchanged through TEFCA, federal health IT office boasts
fiercehealthcare - At the 2026 Annual Meeting for the health IT office at HHS, officials announced a massive spike in the number of health records shared through the government-backed TEFCA initiative. The number seems to reflect the heavy focus Trump's HHS has put on digit…
AI Summary: The federal Trusted Exchange Framework and Common Agreement (TEFCA) has passed roughly 500 million health records exchanged across participating networks, a milestone officials say will accelerate interoperability and data flow. The milestone spotlights rapid uptake and complementary data initiatives—plus the governance and privacy work that now comes with scale.
Federal judge blocks $602M in CDC cuts to 4 states
Kelly Gooch / beckershospitalreview - A federal judge in the Northern District of Illinois granted a temporary restraining order Feb. 12 blocking the Trump administration from terminating more than $600 million in CDC-administered public health grants to California, Colorado, Illinois and Min…
AI Summary: A federal judge issued a temporary restraining order halting the administration’s planned termination of roughly $600M in CDC grants to several states, siding with lawsuits that argued the cuts would impair public-health programs. The order preserves funding while courts consider claims that the move would cause immediate harm.
FDA refuses to review Moderna flu vaccine
Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …
AI Summary: Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making.
Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide
Charles Z. Levkoe, Canada Research Chair in Equitable and Sustainable Food Systems, Lakehead Univers / theconversation - The recent retraction of peer-reviewed research claiming glyphosate is safe confirms what Indigenous communities have said for years.
AI Summary: The recent retraction of a widely cited study asserting glyphosate’s safety has rekindled long‑held Indigenous suspicions about the herbicide. Experts now question its safety profile, calling for more regulatory scrutiny and a re‐evaluation of long‑standing warnings regarding its potential dangers.
Public Health Department confirms first 2026 measles case in Los Angeles County
medicalxpress - The Department of Public Health has confirmed the first measles case this year in Los Angeles County. Officials say the person who tested positive for measles had recently traveled outside the country. The department is now working to identify people who …
AI Summary: Los Angeles County health officials confirmed the first measles case of 2026 even as nationwide data reveal that only one month into the year, case numbers have already reached 25% of 2025’s total. Experts warn that if vaccination rates do not improve promptly, an early outbreak could expand and stress public health systems.
World Cancer Day: A Global Call to Awareness and Action 2026, Part 2
oncodaily - World Cancer Day is observed annually on February 4 and was established in 2000 at the World Summit Against Cancer for the New Millennium in Paris. The initiative was led […]
AI Summary: World Cancer Day 2026, observed on February 4, serves as a global rallying cry to boost cancer awareness, promote early detection, and improve patient access to care. Healthcare professionals, advocates, and patients united at the event to spotlight the critical need for innovation and coordinated action against cancer.
- Early Detection & Access Initiatives (4)
- Other Cancer News (15)
- Research and Treatment Advances (28)
- World Cancer Day Global Events (4)
- All Other Stories
Early Detection & Access Initiatives
Other Cancer News
Research and Treatment Advances
World Cancer Day Global Events
All Other Stories
HHS launches $100M homelessness, addiction treatment initiative
Ella Ruder / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. unveiled a $100 million federal initiative to address homelessness, opioid addiction and public safety following President Donald Trump’s executive order creating the Great American Recovery Initiative. The Safety Throu…
AI Summary: Two nearly identical reports detail a new federal announcement by HHS, which unveiled a $100M initiative aimed at tackling homelessness among individuals with addiction issues. The program is designed to integrate mental health, addiction treatment, and social services to rapidly stabilize vulnerable populations.
MultiCare agrees to $3.7M settlement over allegations it knowingly allowed unnecessary surgeries
fiercehealthcare - The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.
AI Summary: Federal investigators found that MultiCare knowingly allowed a former physician to perform unnecessary spinal surgeries despite multiple warnings, prompting a whistleblower lawsuit. In response, the health system agreed to a $3.7 million settlement to resolve the allegations and avoid further litigation.
HHS to drop 340B rebate pilot after court rulings
Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…
AI Summary: In a twist that no one saw coming (except the federal courts), HHS has scrapped its controversial 340B rebate pilot after two judicial rulings blocked its implementation. Providers, relieved to avoid a potential cash flow nightmare, are quietly celebrating the decision as one less bureaucratic headache to manage.
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Ayisha Sharma / endpoints - Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention. The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...
AI Summary: Bayer’s latest Phase 3 study of asundexian has shown a 26% reduction in secondary ischemic stroke risk—without an increased bleeding risk. This compelling data bolsters the drug’s prospects as a blockbuster in stroke prevention and underscores Bayer’s commitment to advancing cardiovascular therapies.
AI model reads brain MRIs in seconds, hitting up to 97.5% accuracy
medicalxpress - An AI-powered model developed at the University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatme…
AI Summary: Researchers at the University of Michigan have unveiled an AI-powered model that reads brain MRIs in seconds with up to 97.5% accuracy. This breakthrough promises to ease radiologist workloads and dramatically speed up neurodiagnostics, potentially transforming clinical workflows in imaging.
Eikon Therapeutics Raises $381 M in IPO to Advance Live-Cell Imaging in Cancer Drug Discovery
oncodaily - Eikon Therapeutics has raised $381 million through its IPO, pricing at the top of its range in a strong sign of renewed investor appetite for biotech offerings. The South San […]
AI Summary: Eikon Therapeutics successfully raised $381 million in its IPO, reinforcing investor confidence in novel biotechnology approaches for cancer drug discovery. The fundraising milestone is expected to accelerate live‐cell imaging and other innovative oncology research initiatives.
High Consumption of Ultraprocessed Foods May Be Linked to Cancer Survivors’ Risk of Death
Kathleen Medora / aacr - PHILADELPHIA – Cancer survivors who consumed higher amounts of ultraprocessed foods as part of their diet had a significantly increased risk of both all-cause and cancer-specific death, according to a study published in Cancer Epidemiology, Biomarkers & P…
AI Summary: Recent research from a Philadelphia‐based study indicates that cancer survivors consuming high amounts of ultraprocessed foods face significantly increased risks of both overall and cancer‐specific death. Experts stress that optimizing diet post‐treatment is critical for improving long‐term outcomes.
A newborn's death likely linked to the mom drinking raw milk while pregnant
go - Health officials in New Mexico have said a newborn baby died from a listeria infection likely linked to the child's mother drinking raw milk during pregnancy
AI Summary: New Mexico health officials report a tragic newborn death attributed to a listeria infection linked to the mother’s consumption of unpasteurized raw milk during pregnancy, re–igniting long–standing concerns about food safety standards and the risks involved in consuming unregulated dairy products.
HHS scraps 340B rebate pilot in win for hospitals
Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
AI Summary: Federal health officials have reversed course on a highly controversial 340B rebate pilot program after federal courts blocked its implementation – a move hailed by providers as a long‐awaited relief from cash flow and administrative burdens.
Statin pills much safer than advertised, major review finds
bbc - The results, in The Lancet journal, come from trials involving more than 120,000 people comparing statins with a dummy drug or placebo.
AI Summary: Multiple large‐scale analyses have debunked the long‐held worries about statin side effects – it turns out that those pesky symptoms listed on package leaflets are no more common than when taking a placebo. In other words, patients can keep calm and lower cholesterol with confidence.
Plastic Surgeons’ Group Advises Delaying Gender-Affirming Procedures Until Age 19
Andrew Jacobs / nytimes - The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.
AI Summary: Multiple reports confirm that the American Society of Plastic Surgeons is advising that elective gender‐affirming procedures for minors be delayed until patients reach age 19. The recommendation diverges from other medical group views and aims to enhance patient safety by waiting until later adolescence for irreversible surgical interventions.